Browsing: rare disease

Agios Pharmaceuticals is stopping development of a drug for sickle cell disease after mid-stage clinical data showed the molecule failed…

It’s been a busy few months for Servier, which followed its $2.5 billion acquisition of cancer biotech Day One Biopharmaceuticals…